INTERIM RESULTS FROM AN ONGOING PHASE 2 STUDY EVALUATING THE USE OF A MASP-2 INHIBITOR FOR THE TREATMENT OF IGA NEPHROPATHY (IGAN)

被引:0
|
作者
Barratt, Jonathan [1 ]
Leifke, Eckhard [2 ]
Whitaker, Steve [2 ]
DeTulleo, Louis [2 ]
Lafayette, Richard [3 ]
机构
[1] Univ Leicester, Leicester, Leics, England
[2] Omeros Corp, Seattle, WA USA
[3] Stanford Univ, Stanford, CA 94305 USA
关键词
D O I
暂无
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
FP201
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Long-Term Phase 2 Efficacy of the MASP-2 Inhibitor Narsoplimab for Treatment of Severe IgA Nephropathy
    Lafayette, Richard A.
    Carroll, Kevin
    Barratt, Jonathan
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : B10 - B10
  • [2] Safety, Tolerability and Efficacy of Narsoplimab, a Novel MASP-2 Inhibitor for the Treatment of IgA Nephropathy
    Lafayette, Richard A.
    Rovin, Brad H.
    Reich, Heather N.
    Tumlin, James A.
    Floege, Juergen
    Barratt, Jonathan
    [J]. KIDNEY INTERNATIONAL REPORTS, 2020, 5 (11): : 2032 - 2041
  • [3] MASP-2 inhibition as a potential strategy for the management of IgA nephropathy
    Barratt, J.
    Lafayette, R.
    [J]. DRUGS OF THE FUTURE, 2020, 45 (06) : 389 - 396
  • [4] Atrasentan for the Treatment of IgA Nephropathy: Interim Results From the AFFINITY Study
    Rastogi, Anjay
    Rheault, Michelle N.
    Kim, Sung Gyun
    Vo, Nam D.
    Ranganathan, Dwarakanathan
    Inker, Lesley A.
    Packham, David K.
    Vishnepolsky, Mark
    Sheth, Khushboo
    DeVries, Todd
    Camargo, Marianne
    King, Andrew J.
    Jones-Burton, Charlotte
    Wong, Muh Geot
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 187 - 187
  • [5] ATRASENTAN FOR THE TREATMENT OF IGA NEPHROPATHY: INTERIM RESULTS FROM THE AFFINITY STUDY
    Kim, Sung-Gyun
    Nam Vo
    Lee, Sang-Ho
    Ranganathan, Dwarakanathan
    Inker, Lesley
    El-Shahawy, Mohamed
    Spinelli, Terri
    Sheth, Khushboo
    Devries, Todd
    Camargo, Marianne
    King, Andrew
    Glicklich, Alan
    Wong, Muh
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I816 - I817
  • [6] EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH IGA NEPHROPATHY (IGAN): INTERIM ANALYSIS (IA) OF THE PHASE 3 APPLAUSE-IGAN STUDY
    Rizk, Dana V.
    Kollins, Dmitrij
    Papachristofi, Olympia
    Hach, Thomas
    Jacinto-Sanders, Severina
    Merkel, Tobias
    Renfurm, Ronny
    Perkovic, Vlado
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2024, 83 (05) : 699 - 700
  • [7] Efficacy and safety of iptacopan in patients with primary IgA nephropathy: interim analysis results of the Phase 3 APPLAUSE-IgAN study
    Perkovic, Vlado
    Kollins, Dmitrij
    Papachristofi, Olympia
    Hach, Thomas
    Jacinto-Sanders, Severina
    Merkel, Tobias
    Renfurm, Ronny
    Rizk, Dana V.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I255 - I256
  • [8] UPDATED INTERIM RESULTS OF A PHASE 1/2 STUDY OF BION-1301 IN PATIENTS WITH IGA NEPHROPATHY
    Barratt, Jonathan
    Kooienga, Laura
    Agha, Irfan
    Ruiz-Ramon, Pablo
    Madan, Arvind
    Thomas, Hanna
    Sorensen, Bess
    Leiske, Jocelyn
    Khawaja, Zeeshan
    King, Andrew
    Jones-Burton, Charlotte
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I394 - I394
  • [9] Updated Interim Results of a Phase 1/2 Study of BION-1301 in Patients With IgA Nephropathy
    Barratt, Jonathan
    Kooienga, Laura
    Agha, Irfan
    Thomas, Hanna
    Workeneh, Biruh
    Iyer, Sai Prasad N.
    Narayanan, Rangaraj
    Sathaliya, Taher
    Sorensen, Bess
    Schwartz, Brian S.
    King, Andrew J.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 503 - 503
  • [10] Interim Results from the Ongoing Open-Label Extension of the Phase 2 Trial Evaluating Ralinepag for the Treatment of Pulmonary Arterial Hypertension
    McLaughlin, V. V.
    Ristic, A. D.
    Jansa, P.
    Klings, E. S.
    Barbera, J. A.
    Keogh, A.
    Adams, J.
    Walsh, B.
    Zhang, J. K.
    Cabell, C.
    Klassen, P.
    Rubin, L.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199